Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is caused by the expansion of a polyglutamine repeat in the ataxin-3 protein. We generated a mouse model of SCA3 expressing ataxin-3 with 148 CAG repeats under the control of the huntingtin promoter, resulting in ubiquitous expression throughout the whole brain. The model resembles many features of the disease in humans, including a late onset of symptoms and CAG repeat instability in transmission to offspring. We observed a biphasic progression of the disease, with hyperactivity during the first months and decline of motor coordination after about 1 year of age; however, intranuclear aggregates were not visible at this age. Few and small intranuclear aggregates appeared first at the age of 18 months, further supporting the claim that neuronal dysfunction precedes the formation of intranuclear aggregates.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2009.08.002DOI Listing

Publication Analysis

Top Keywords

intranuclear aggregates
12
mouse model
8
spinocerebellar ataxia
8
ataxia type
8
cag repeats
8
transgenic mouse
4
model spinocerebellar
4
type resembling
4
resembling late
4
disease
4

Similar Publications

Unlabelled: RNA-driven protein aggregation leads to cellular dysregulation by sequestering regulatory proteins, disrupting normal cellular processes, and contributing to the development of diseases and tumorigenesis. Here, we show that double homeobox 4 (DUX4), an early embryonic transcription factor and causative gene of facioscapulohumeral muscular dystrophy (FSHD), induces the accumulation of stable intranuclear RNAs, including nucleolar-associated RNA and human satellite II (HSATII) repeat RNA. Stable intranuclear RNAs drive protein aggregation in DUX4-expressing muscle cells.

View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy is a promising cancer treatment that relies on immune cells in the tumor microenvironment, with "hot tumors" showing better results due to high immune cell presence.
  • Previous research indicated that secretagogin (SCGN) decreases in expression as clear cell renal cell carcinoma (ccRCC) progresses, though it doesn't affect cancer cell traits directly.
  • This study shows that SCGN can influence immune responses by regulating cytokine/chemokine secretion and attracting immune cells, particularly M1 macrophages, through the NF-κB signaling pathway, suggesting that maintaining SCGN expression could be a potential therapeutic strategy for ccRCC.
View Article and Find Full Text PDF
Article Synopsis
  • The NOTCH2NLC gene is linked to several neurological disorders through expansions of GGC repeats in its 5' untranslated region, which can lead to conditions like Parkinson's, dementia, and tremors.
  • The study used cellular models and CRISPR-Cas9 engineered mice with specific GGC repeat variations to investigate the effects of these repeats, particularly focusing on those with serine insertions.
  • Results showed that a specific intermediate repeat with serine insertion caused mitochondrial dysfunction and neurotoxicity, leading to PD-like symptoms in mice, including neuronal loss and behavioral impairments.
View Article and Find Full Text PDF

Mouse kidney parvovirus (MKPV) infection can cause significant morbidity and mortality by inducing moderate to severe inclusion body nephropathy and kidney fibrosis in aged immunodeficient mice. However, MKPV infection in immunocompetent mice is associated with histopathologic findings ranging from absent to minimal or moderate lymphoplasmacytic interstitial nephritis without inclusion body in most cases. We surveyed the prevalence of MKPV via PCR from August 2019 through January 2021, using feces, kidneys, and livers collected and pooled from 2 sentinel mice [Crl:CD1(ICR)] (CD1) per surveillance cage (a total of 212 cages).

View Article and Find Full Text PDF
Article Synopsis
  • A hexanucleotide repeat expansion in a specific gene is a primary genetic cause of ALS and FTD, with proposed mechanisms including haploinsufficiency and dipeptide repeat proteins.
  • The study identifies effective disease-modifying siRNAs that can reduce the expression of harmful mRNA variants in a mouse model of ALS/FTD.
  • Results indicate that targeting all mRNA variants provides better results for reducing toxic RNA aggregates than focusing solely on HRE-containing mRNA, suggesting a promising RNA interference approach for therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!